✨ Free AI Report
DiaSorin S.p.A.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research DiaSorin S.p.A.
Company Research

DiaSorin S.p.A.: Business Overview, Financials & Competitive Analysis

DiaSorin develops and manufactures a broad portfolio of in vitro diagnostics used for detecting pathogens and contamination of samples from the human body, as well as used in industrial settings such as food and water...

Analyst-debate audio for DiaSorin S.p.A.

AskCyborg analysts argue the bull and bear cases for DiaSorin S.p.A. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
7/ 10Strong

Cyborg Score thesis

Established global IVD leader with recurring revenue model and diversified product portfolio positioned to capture growing...

Read the full analyst-debate transcript →
Industry In Vitro Diagnostics / Medical Diagnostics
5 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest DiaSorin S.p.A. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

DiaSorin S.p.A. Overview

Pro stress-test →

DiaSorin develops and manufactures a broad portfolio of in vitro diagnostics used for detecting pathogens and contamination of samples from the human body, as well as used in industrial settings such as food and water contamination testing. The company operates a dual-channel business model selling diagnostic machines to laboratories while providing recurring revenue from consumables needed for diagnostics.

Strategic Profile

Pro stress-test →

The Group operates across five continents through 35 companies, 4 branches, 10 manufacturing facilities, and 9 research and development centers. The company operates three segments: immunodiagnostics (66% of sales), molecular diagnostics (17%), and licensed technologies (14%). Notable brands include LIAISON and Verigene systems, along with xMAP technology.

Competitive Landscape

Pro stress-test →

Key competitors include Bio-Rad Laboratories, QuidelOrtho, Revvity, Randox, and BioMérieux. DiaSorin maintains differentiation through its proprietary automation platforms, global distribution network, and integrated equipment-plus-reagent business model. The competitive landscape remains fragmented with major players competing on technology innovation, geographic reach, and product breadth.

Industry Context

DiaSorin S.p.A. operates in In Vitro Diagnostics / Medical Diagnostics.

Key facts

Founded: 1968 · Headquarters: Saluggia, Italy · Employees: 3,280 · Revenue: $1.32B · Market cap: $4.68B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on DiaSorin S.p.A..

  • Recession-resistant recurring revenue model through dual-channel approach (equipment + consumables) ensures predictable cash generation
  • Post-COVID normalization impacting core revenue growth—COVID tests declined from 8% to 2% of sales between 2022-2024
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Stock price at €88.73 with market cap of €4.68B, reflecting valuation pressures from macro headwinds
  • 2025H1 revenue of €619M (up 5% YoY) with core business excluding COVID growing 8%, indicating underlying strength
  • +2 moreTrack every material event for DiaSorin S.p.A. as it happens. Explore monitoring →
Get alerted when DiaSorin S.p.A. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Bio-Rad LaboratoriesClinical diagnostics and life science research products→QuidelOrthoPoint-of-care and laboratory diagnostics→RevvityDiagnostics and life sciences solutions→BioMérieuxIn vitro diagnostics for infectious diseases→RandoxClinical diagnostics and quality assurance→

Compare DiaSorin S.p.A. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

DiaSorin S.p.A. operates in In Vitro Diagnostics / Medical Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse In Vitro Diagnostics / Medical Diagnostics research →
NEW · MCP server

Ask your AI assistant about DiaSorin S.p.A.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare DiaSorin S.p.A. and its top competitor on Cyborg Score”
“What did DiaSorin S.p.A. do this quarter?”
“Is DiaSorin S.p.A. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com · Terms of Service

Frequently asked questions

What does DiaSorin S.p.A. do?+
DiaSorin develops and manufactures a broad portfolio of in vitro diagnostics used for detecting pathogens and contamination of samples from the human body, as well as used in industrial settings such as food and water...
What is DiaSorin S.p.A.'s Cyborg Score?+
DiaSorin S.p.A. has a Cyborg Score of 7/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are DiaSorin S.p.A.'s main competitors?+
Named competitors include Bio-Rad Laboratories, QuidelOrtho, Revvity, BioMérieux. The full competitive landscape is in the AskCyborg report.
How can I get the full DiaSorin S.p.A. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the DiaSorin S.p.A. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track DiaSorin S.p.A. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More In Vitro Diagnostics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7DiaSorin S.p.A.7Shenzhen New Industries Biomedical Engineering Co., Ltd.4Biosynex SA3QuidelOrtho Corporation7Revvity, Inc.